Switch theme
Sign up to access all valuation multiples
CareNet Inc is a marketing company providing various solutions to pharma companies through the management of media specialized in medical/pharmaceutical education for HCPs.
1996
118
LTM Revenue $76.7M
LTM EBITDA $17.9M
$157M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CareNet has a last 12-month revenue of $76.7M and a last 12-month EBITDA of $17.9M.
In the most recent fiscal year, CareNet achieved revenue of $74.3M and an EBITDA of $15.3M.
CareNet expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CareNet valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $68.0M | $74.3M | XXX | XXX | XXX |
| Gross Profit | $42.6M | $43.1M | XXX | XXX | XXX |
| Gross Margin | 63% | 58% | XXX | XXX | XXX |
| EBITDA | $17.7M | $15.3M | XXX | XXX | XXX |
| EBITDA Margin | 26% | 21% | XXX | XXX | XXX |
| Net Profit | $12.3M | $10.0M | XXX | XXX | XXX |
| Net Margin | 18% | 14% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, CareNet's stock price is JPY 718 (or $5).
CareNet has current market cap of JPY 30.8B (or $205M), and EV of JPY 23.6B (or $157M).
See CareNet trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $157M | $205M | XXX | XXX | XXX | XXX | $0.20 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, CareNet has market cap of $205M and EV of $157M.
CareNet's trades at 2.0x LTM EV/Revenue multiple, and 8.8x LTM EBITDA.
Analysts estimate CareNet's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for CareNet and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $157M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 10.3x | XXX | XXX | XXX |
| P/E | 27.0x | XXX | XXX | XXX |
| P/E/Growth | 0.8x | XXX | XXX | XXX |
| EV/FCF | 13.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCareNet's NTM/LTM revenue growth is 11%
CareNet's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, CareNet's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate CareNet's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for CareNet and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -14% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 32% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 40% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CareNet acquired XXX companies to date.
Last acquisition by CareNet was XXXXXXXX, XXXXX XXXXX XXXXXX . CareNet acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was CareNet founded? | CareNet was founded in 1996. |
| Where is CareNet headquartered? | CareNet is headquartered in Japan. |
| How many employees does CareNet have? | As of today, CareNet has 118 employees. |
| Is CareNet publicy listed? | Yes, CareNet is a public company listed on TKS. |
| What is the stock symbol of CareNet? | CareNet trades under 2150 ticker. |
| When did CareNet go public? | CareNet went public in 2007. |
| Who are competitors of CareNet? | Similar companies to CareNet include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
| What is the current market cap of CareNet? | CareNet's current market cap is $205M |
| What is the current revenue of CareNet? | CareNet's last 12-month revenue is $76.7M. |
| What is the current EBITDA of CareNet? | CareNet's last 12-month EBITDA is $17.9M. |
| What is the current EV/Revenue multiple of CareNet? | Current revenue multiple of CareNet is 2.0x. |
| What is the current EV/EBITDA multiple of CareNet? | Current EBITDA multiple of CareNet is 8.8x. |
| What is the current revenue growth of CareNet? | CareNet revenue growth between 2023 and 2024 was 9%. |
| Is CareNet profitable? | Yes, CareNet is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
